Among active 13F managers last quarter, 1 opened and 1 reduced; the largest holder to move was Advisory Alpha, LLC (new position). Over the last 180 days, 1 insider sold and none bought, a net -$13 in open-market trades.
The legs disagree, or only one of them leans.
10 tracked 13F filers disclose a position in DRMA as of the latest SEC 13F filings, a combined $135K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 36K | $43K | ▲29× Added · +34K sh | Q1 2026 | |
| 2 | Geode Capital Management, LLC | 20K | $26K | ▼−58% Reduced · −28K sh | Q2 2026 | |
| 3 | Welch & Forbes LLC | 20K | $26K | —Held | Q2 2026 | |
| 4 | State Street Corp | 19K | $24K | ▲New +19K sh | Q2 2026 | |
| 5 | Advisory Alpha, LLC | 10K | $13K | ▲New +10K sh | Q2 2026 | |
| 6 | MCF Advisors LLC | 2K | $2K | —Held | Q2 2026 | |
| 7 | Tower Research Capital LLC (TRC) | 716 | $866 | ▼−64% Reduced · −1K sh | Q1 2026 | |
| 8 | SBI Securities Co., Ltd. | 101 | $130 | —Held | Q2 2026 | |
| 9 | Highline Wealth Partners LLC | 26 | $34 | ▲New +26 sh | Q2 2026 | |
| 10 | Citigroup Inc | 1 | $1 | ▲New +1 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund opened a new position in DRMA, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 5 funds | $1.2B |
| Apple IncAAPL | 5 funds | $806.6M |
| Vanguard S&P 500 ETFVOO | 5 funds | $564.0M |
| Microsoft CorpMSFT | 5 funds | $539.1M |
| Alphabet Inc-CL CGOOG | 5 funds | $522.1M |
| Alphabet Inc-CL AGOOGL | 5 funds | $327.9M |
| Visa Inc-Class A SharesV | 5 funds | $294.7M |
| Amazon.com IncAMZN | 5 funds | $287.2M |
| JPMorgan Chase & CoJPM | 5 funds | $263.3M |
| Eli Lilly & CoLLY | 5 funds | $255.0M |
| Micron Technology IncMU | 5 funds | $228.7M |
| Johnson & JohnsonJNJ | 5 funds | $224.2M |
Ranked by how many of DRMA's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in DRMA.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Scott Kathleen D. | Director | Sell (S) | 11 | $13 |
| Feb 17, 2026 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Buy (P) | 1K | $1K |
| Nov 23, 2021 | Proehl Gerald T | President, CEO and Chairman, Director, 10% Owner | Buy (P) | 20K | $48K |
| Aug 17, 2021 | Proehl Gerald T | President, CEO and Chairman, Director, 10% Owner | Buy (P) | 143K | — |
| Aug 17, 2021 | Hale David F | Director, 10% Owner | Buy (P) | 36K | — |
| Aug 16, 2021 | Proehl Gerald T | President, CEO and Chairman, Director, 10% Owner | Buy (P) | 10K | $50K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 1 | 2 | – |
Insiders Form 4 open-market | 0 | 1 | -$13 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| DRMAthis pageStock | 10 funds | $135K |
| DRMAW*W EXP 99/99/999 | 2 funds | $16K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for DRMA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DRMA/capital-change-brief"
Use Arkolith's capital_change_brief for DRMA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DRMA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.